Patents by Inventor John Michael Berge

John Michael Berge has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MACROLONES
    Publication number: 20090170791
    Abstract: A compound of formula (I) or a pharmaceutically acceptable derivative thereof, having antimicrobial activity, processes for their preparation, compositions containing them and to their use in medicine.
    Type: Application
    Filed: November 7, 2006
    Publication date: July 2, 2009
    Inventors: Sulejman Alihodzic, John Michael Berge, Catherine Simone Victoire Frydrych, Samra Kapic, Ivana Palej
  • Compounds
    Patent number: 7351696
    Abstract: The present invention relates to compounds of formula (I) and pharmaceutically acceptable derivatives thereof, to processes for their preparation and their use in therapy or prophylaxis of systemic or topical microbial infections in a human or animal body.
    Type: Grant
    Filed: October 29, 2003
    Date of Patent: April 1, 2008
    Assignee: Glaxo Group Limited
    Inventors: John Michael Berge, Catherine Simone Victoire Frydrych, Richard Lewis Jarvest
  • Quinolones used as MRS inhibitors and bactericides
    Patent number: 6320051
    Abstract: Compounds of formula (I) are inhibitors of the bacterial enzyme S aureus methionyl tRNA synthetase and are of use in treating bacterial infections.
    Type: Grant
    Filed: October 26, 2000
    Date of Patent: November 20, 2001
    Assignee: SmithKline Beecham plc
    Inventors: John Michael Berge, Pamela Brown, John Stephen Elder, Andrew Keith Forrest, Dieter Wolfgang Hamprecht, Richard Lewis Jarvest, David Jonathan McNair, Robert John Sheppard
  • Derivatives of 4-(2-aminoethyl)phenoxymethyl-phosphonic and -phosphinic acid and pharmaceutical and veterinary uses therefor
    Patent number: 5726165
    Abstract: A compound of formula (I): ##STR1## or a pharmaceutically acceptable salt, or solvate thereof, wherein,R.sup.o represents an aryl group, optionally substituted;X represents O or S;R.sup.1 and R.sup.1a each independently represents hydrogen or an alkyl group;R.sup.2 represents OCH.sub.2 CO.sub.2 H, or an ester or amide thereof, or R.sup.2 represents a moiety of formula (b): ##STR2## wherein R.sup.4 represent hydrogen, alkyl, hydroxyalkyl, arylalkyl, aralkyloxyalkyl or cycloalkyl and R.sup.5 represent hydroxy, alkoxy, arylalkyloxy, hydroxyalkyloxy, alkoxyalkyloxy, arylalkoxyalkyloxy, cycloalkyloxy, hydrogen, alkyl, substituted alkyl, cycloalkyl, aryl, arylalkyl, arylalkyloxyalkyl or R.sup.5 together with OR.sup.4 represents O(CH.sub.2).sub.n O wherein n is 2, 3 or 4; andR.sup.3 represents hydrogen, halogen, alkyl or alkoxy or R.sup.3 together with R.sup.
    Type: Grant
    Filed: June 5, 1995
    Date of Patent: March 10, 1998
    Assignee: SmithKline Beecham p.l.c.
    Inventors: Lee James Beeley, Mervyn Thompson, David Kenneth Dean, Nikesh Rasiklal Kotecha, John Michael Berge, Robert William Ward